Parkinson's Disease Foundation Report issue

Foundation Phase 2 Phase 4

Organization Overview

First Clinical Trial
2004
NCT00296946
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Parkinson's Disease Foundation